Results 51 to 60 of about 495,297 (403)

Aspirin “Allergy”-Induced Thrombocytopenia: A Case Report

Journal of Asthma and Allergy, 2021
Wei Fu, Shanshan Xu, Xiang Dong, Qing Xie, Yadong Gao Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of ChinaCorrespondence: Yadong Gao; Wei FuDepartment of Allergology, Zhongnan Hospital of Wuhan ...
Fu W, Xu S, Dong X, Xie Q, Gao Y
doaj  

'Aspirin resistance' or treatment non-compliance: Which is to blame for cardiovascular complications?

Journal of Translational Medicine, 2008
Aspirin is one of the 'cornerstone' drugs in our current management of cardiovascular disorders. However, despite the prescription of aspirin recurrent vascular events still occur in 10–20% of patients.
Shantsila Eduard, Lip Gregory YH
doaj   +1 more source

Model mass spectrometric study of competitive interactions of antimicrobial bisquaternary ammonium drugs and aspirin with membrane phospholipids [PDF]

, 2013
The aim of the study is to reveal molecular mechanisms of possible activity modulation of antimicrobial bis-quaternary ammonium compounds (BQAC) and aspirin (ASP) through noncovalent competitive complexation under their combined introduction into the ...
Gömöry, Ágnes, Kosevich, M. V., Pashynska, V. A., Vékey, Károly   +3 more
core   +2 more sources

Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019

Anesthesia and Analgesia, 2020
BACKGROUND: Coronavirus disease-2019 (COVID-19) is associated with hypercoagulability and increased thrombotic risk in critically ill patients. To our knowledge, no studies have evaluated whether aspirin use is associated with reduced risk of mechanical ...
J. Chow, A. Khanna, S. Kethireddy, D. Yamane, A. Levine, Amanda M. Jackson, M. McCurdy, A. Tabatabai, G. Kumar, P. Park, I. Benjenk, Jay Menaker, Nayab Ahmed, Evan Glidewell, Elizabeth Presutto, Shannon Cain, Naeha Haridasa, Wesley Field, Jacob G. Fowler, D. Trinh, Kathleen N. Johnson, Amanjyot Kaur, A. Lee, Kyle Sebastian, Allison Ulrich, S. Peña, R. Carpenter, S. Sudhakar, Pushpinder Uppal, Benjamin T. Fedeles, Aaron Sachs, Layth Dahbour, W. Teeter, Kenichi A. Tanaka, Samuel M. Galvagno, D. Herr, T. Scalea, Michael A. Mazzeffi   +37 more
semanticscholar   +1 more source

The association of aspirin use with overall survival of patients with inoperable non-small cell lung cancer: a retrospective study

BMC Cancer, 2021
Background Studies have indicated that individuals taking aspirin have a reduced risk of cancers and have also established chemo-preventive benefit of aspirin in colorectal cancer. However, research on the association between aspirin use and the survival
Min-Chun Chuang, Yao-Hsu Yang, Meng-Jer Hsieh, Yu-Ching Lin, Tsung-Ming Yang, Pau-Chung Chen, Ming-Szu Hung   +6 more
doaj   +1 more source

Exploring the equity of GP practice prescribing rates for selected coronary heart disease drugs: a multiple regression analysis with proxies of healthcare need [PDF]

, 2005
Background There is a small, but growing body of literature highlighting inequities in GP practice prescribing rates for many drug therapies. The aim of this paper is to further explore the equity of prescribing for five major CHD drug groups and to ...
A Gibson, A Majeed, A Majeed, A Majeed, A Williams, AM Tod, Antony S St Leger, B Hope, BH Foundation, C Baxter, C Packham, C Packham, D Health, D Health, D Health, D Health, DC Lloyd, DC Lloyd, EUROASPIREII Group., FA Majeed, FA Majeed, FDA Reid, G Davey-Smith, G Davey-Smith, GC Fonarow, H Cooper, H Tunstall-Pedoe, J Bedson, J Hippisley-Cox, J Tudor Hart, JHS Unit, JI Mann, JY Nazroo, K Gardner, M Frischer, M Goddard, M Pringle, M Whitehead, M Whitehead, MC MacLeod, MG Hunink, MG Patel, N Bradshaw, N Chaturvedi, N Danchin, N Rice, NC Campbell, NHS Centre for Reviews and Dissemination, ON Statistics, P Jousilahti, P Primatesta, P Suadicani, P Townsend, Paul R Ward, Peter R Noyce, PG Steg, PH Whincup, PR Ward, PR Ward, PR Ward, PS Unit, PS Unit, R Bhopal, R Bhopal, RM Haynes, S Hopper, S Kerrison, S Langham, S Peckham, SM Bogle, SR Chapman, SS Gottlieb, T Crayford, T Morton-Jones, T Walley, TJ Wang, V Salomaa, WH Organisation.   +77 more
core   +4 more sources

Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis

Journal of the American Medical Association (JAMA), 2019
Importance The role for aspirin in cardiovascular primary prevention remains controversial, with potential benefits limited by an increased bleeding risk.
Sean Zheng, A. Roddick
semanticscholar   +1 more source

Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia

Stroke Research and Treatment, 2021
Objective. To evaluate the aspirin resistance prevalence in patients with previous ischemic cerebrovascular disease undergoing aspirin therapy for secondary prevention. Materials and Methods.
Alejandro Roman-Gonzalez, Carlos Andrés Naranjo, Walter D. Cardona-Maya, Dionis Vallejo, Francisco Garcia, Cesar Franco, Leonor Alvarez, Luis Ignacio Tobón, Marta Ibeth López, Carolina Rua, Gabriel Bedoya, Ángela Cadavid, José Domingo Torres   +12 more
doaj   +1 more source

Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. [PDF]

, 2006
BACKGROUND AND PURPOSE: Aspirin resistance may be relatively common and associated with adverse outcome. Meta-analysis has clearly shown that 75 mg plain aspirin is the lowest effective dose; however, it is not known whether the recent increased use of ...
Byrne, Michael F, Conroy, Ronán, Cox, Dermot, Dooley, Michelle, Fitzgerald, Desmond J, Maree, Andrew O   +5 more
core   +1 more source

Effect of Aspirin on All‐Cause Mortality in the Healthy Elderly

New England Journal of Medicine, 2018
BACKGROUND In the primary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) trial, now published in the Journal, we report that the daily use of aspirin did not provide a benefit with regard to the primary end point of disability‐free ...
J. McNeil, M. Nelson, R. Woods, J. Lockery, R. Wolfe, C. Reid, B. Kirpach, R. Shah, D. Ives, E. Storey, J. Ryan, A. Tonkin, A. Newman, J. Williamson, K. Margolis, M. Ernst, W. Abhayaratna, N. Stocks, S. Fitzgerald, S. Orchard, R. Trevaks, L. Beilin, G. Donnan, P. Gibbs, C. Johnston, B. Radziszewska, R. Grimm, A. Murray   +27 more
semanticscholar   +1 more source